Found
Found is a US-based telehealth platform delivering personalized weight loss treatment through GLP-1 medications, clinical consultations, and behavioral coaching. The company serves 300,000+ lifetime members via subscriptions, employer partnerships, and insurance networks covering 1 in 3 Americans.
- Company typePrivate
- Founded2019
- HeadquartersSan Francisco, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Found does
Found (Found Health, Inc.) is a US-based direct-to-consumer telehealth platform that delivers personalized obesity treatment, primarily through GLP-1 medications combined with clinical consultations, 1:1 health coaching, and a behavior change program. The platform targets adults with a BMI ≥30, or BMI ≥27 with a weight-related condition, connecting them to board-certified clinicians trained in obesity medicine via a web and mobile application. As of available data, Found has served over 300,000 lifetime members, booked more than 1 million clinician consultations, and reports an average 12% body weight loss across members over one year, with 83% sustaining results at twelve months.
The product surface is unusually broad for a weight care telehealth player: 10+ medications including compounded semaglutide and tirzepatide, branded GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro), oral GLP-1s (Rybelsus, Foundayo/orforglipron), and non-GLP-1 oral alternatives (metformin, topiramate, Contrave, bupropion/naltrexone). Differentiated features include a GLP-1 microdosing program, an exclusive in-app community, an insurance coverage checker, AI-powered chatbots for member support, and clinical protocols designed under a senior medical advisor and Chief Medical Officer. Clinical care is delivered through contracted medical groups (Pippen Health, Cloud Health Medical Group, SteadyMD) operating under Found ACE/OCHA arrangements for HIPAA-compliant care coordination.
Revenue is generated through recurring monthly subscriptions (Compounded GLP-1 Plan from $99/month, Generics Plan from $49/month, Branded GLP-1 Plan from $650/month), medication sales through partner pharmacies, insurance-billed clinical visits (sub-$30 copays for most members), and optional lab services. Customer acquisition runs through paid social (Meta), paid search, SEO, organic social on Instagram, TikTok, Facebook, and LinkedIn, content marketing, and referral programs. Distribution includes in-network relationships with six major US insurance carriers covering roughly 1 in 3 Americans, direct fulfillment partnerships with Novo Nordisk (NovoCare) and Eli Lilly (LillyDirect), and emerging B2B channels for employer-sponsored weight care benefits and health plan collaborations.
Found firmographics
Firmographics- Name
- Found
- Legal name
- Found Health, Inc.
- Website
- https://joinfound.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Found is a US-based telehealth platform delivering personalized weight loss treatment through GLP-1 medications, clinical consultations, and behavioral coaching. The company serves 300,000+ lifetime members via subscriptions, employer partnerships, and insurance networks covering 1 in 3 Americans.
- Ownership category
- akta.pro rank
Found industry classification
Industry- Product category
- Telehealth Weight Management
- NAICS
- Diet and Weight Reducing Centers (812191), Offices of Physicians (6211), Pharmacies and Drug Retailers (45611)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Obesity Medicine & Weight Management (HLAKADAL)
- akta.pro secondary industries
- Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD), Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH), Copay Assistance, Patient Support & Affordability Programs (HLAEAKAI), Weight Management & Behavior Change Education (EDAAAHAF)
Keywords
Where Found is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Found business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Subscription Fees (Membership): Monthly subscription fees for access to the platform, medical consultations, care coordination, and support services. Found offers Compounded GLP-1 plans, Generics plans, and Branded GLP-1 plans with varying price points. Subscription fees are not covered by insurance and are considered a Non-Covered Service.
- Medication Sales: Revenue from dispensing compounded GLP-1 medications and facilitating branded GLP-1 prescriptions through partner pharmacies. Compounded medications are billed separately from subscription fees and are not covered by insurance.
- Clinical Visit Fees (Insurance Billable): Medical consultations billed to insurance carriers for clinical visits. Most members pay less than $30/visit through insurance coverage. This is separate from the membership subscription fee.
- Laboratory Services: Optional laboratory testing services offered to members, billed either through insurance or self-pay cash basis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Compounded GLP-1 Plan - Full program with personalized assessment, access to specialists, compounded GLP-1 medication, 1:1 health coaching, lifestyle tools, and member community |
| Subscription | Monthly | Generics Plan (Oral Non-GLP-1s) - Access to generic oral non-GLP-1 medications |
| Subscription | Monthly | Branded GLP-1 Plan - Access to branded GLP-1 prescriptions like Wegovy and Zepbound with coaching and app tools |
| Subscription | Monthly | Clinical Visits (Insurance-Covered) |
| Subscription | Annual | Annual/Prepaid Plans |
| Unit Pricing | Monthly | Ozempic |
| Unit Pricing | Monthly | Mounjaro |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels10 records
Found product offering
Product offeringCore offering
Found operates a direct-to-consumer telehealth weight care platform delivering personalized obesity treatment through board-certified clinicians, prescription medications (compounded GLP-1s, branded GLP-1s including Wegovy and Zepbound, the oral GLP-1 Foundayo/orforglipron, and non-GLP-1 options), a GLP-1 microdosing program, 1:1 health coaching, and an in-app community with behavior change support. Members access care through a web portal and mobile app, receive medications via partner pharmacies, and may use insurance coverage for clinical visits with most paying under $30 per visit.
Product overview
Found is a comprehensive telehealth weight care platform offering a unified ecosystem of clinical services, prescription medications, and digital support tools. The platform's core offering centers on GLP-1 medications (both branded and compounded formulations including semaglutide, tirzepatide, and the oral orforglipron/Foundayo), supported by telehealth consultations with obesity medicine specialists, 1:1 health coaching, and an app with community features and tracking tools. The platform operates on subscription-based plans (Compounded GLP-1 Plan, Generics Plan, and Branded GLP-1 Plan) that bundle clinical care, medications, and coaching services, with additional insurance navigation support.
Differentiator
Problem solved
Functional benefit
Brands
- Foundayo: Oral GLP-1 weight loss medication (orforglipron) offered by Found.
Products and services
- Found GLP-1 Weight Loss Program Telehealth weight care program offering GLP-1 medications (branded and compounded) along with clinical consultations, coaching, and app-based support tools for personalized weight loss treatment.
- GLP-1 Microdosing Program A simplified way to start GLP-1 medications using smaller doses, designed to help members begin treatment with potentially fewer side effects.
- Found App Mobile application providing in-app community support, expert-designed behavior change program, tracking tools, and access to care team communications.
- Telehealth Consultations Online medical consultations with board-certified providers specializing in obesity medicine for weight care treatment planning.
- Compounded Semaglutide Compounded version of semaglutide (GLP-1 receptor agonist) available for weight management, offered as an affordable alternative to brand-name versions.
- Compounded Tirzepatide Compounded version of tirzepatide (dual GIP/GLP-1 receptor agonist) for weight management, offered as an affordable alternative to brand-name options.
- Foundayo (Orforglipron) Oral GLP-1 weight loss medication (orforglipron), an oral small molecule GLP-1 receptor agonist approved for weight management, offering a non-injectable alternative.
- Ozempic (Semaglutide) FDA-approved brand-name semaglutide injection (GLP-1 receptor agonist) for weight management.
- Wegovy (Semaglutide) FDA-approved brand-name semaglutide injection specifically indicated for chronic weight management.
- Zepbound (Tirzepatide) FDA-approved brand-name tirzepatide injection (dual GIP/GLP-1 receptor agonist) for weight management.
- Mounjaro (Tirzepatide) FDA-approved brand-name tirzepatide injection for weight management.
- Saxenda (Liraglutide) FDA-approved brand-name liraglutide injection for weight management.
- Victoza (Liraglutide) FDA-approved liraglutide injection, prescribed off-label for weight management.
- Rybelsus (Semaglutide) FDA-approved oral semaglutide tablet for weight management.
- Trulicity (Dulaglutide) FDA-approved GLP-1 receptor agonist injection for weight management.
- Metformin FDA-approved oral medication typically used for diabetes, prescribed off-label for weight management.
- Contrave FDA-approved weight loss medication (bupropion/naltrexone combination) available through the platform.
- Topiramate Anti-epileptic medication prescribed off-label for weight management.
- Zonisamide Anti-seizure medication prescribed off-label for weight management.
Quantifiable outcome
- Up to 15-20% weight loss with Wegovy and Zepbound
- +5 more outcomes
Companies that use Found
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Found technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability4 records
Feature5 records
Found partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- United HealthcarecoreMajor insurance carrier partner accepting Found's weight care services. Coverage varies by state and plan.
- AetnacoreInsurance carrier partner providing coverage for Found's telehealth weight care services and medications.
- CignacoreInsurance carrier partner for weight care coverage through Found's platform.
- Blue Cross Blue ShieldcoreMajor insurance carrier partner covering Found's weight care services across multiple states.
- AnthemcoreInsurance carrier partner for weight management coverage through Found's telehealth platform.
- Highmark HealthcoreInsurance carrier partner providing coverage options in multiple states.
- Pippen Health (Delaware, California, Texas, New Jersey)coreMedical groups contracted to provide telehealth medical consultations and secure messaging with patients. Part of Found ACE (Affiliated Covered Entity) for HIPAA compliance.
- Cloud Health Medical Group (PA, California, New Jersey, Kansas)coreMedical groups participating in Found OCHA (Organized Health Care Arrangement) for joint care coordination and PHI sharing.
- SteadyMD Physician GroupminorAffiliated medical group contracted to provide online telehealth medical consultations.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Found competitors and assessment
Company assessmentDirect peers
- Ro: Ro operates the Ro Body Program, a direct-to-consumer telehealth weight loss offering with compounded and branded GLP-1s, telehealth consultations, and coaching. Ro is the most directly comparable platform to Found across product breadth, GTM motion, and pricing structure.
- Hims & Hers Health: Hims & Hers offers telehealth weight loss programs including branded and compounded GLP-1s alongside its broader men's and women's health verticals. The company is a direct competitor with overlapping customer acquisition channels and a comparable subscription model.
- Calibrate: Calibrate is a metabolic health and weight loss telehealth platform pairing GLP-1 prescribing with behavior change coaching on a subscription basis. Comparable to Found's combined medication-plus-coaching model.
- Noom: Noom combines behavior change programs with newer telehealth medication offerings including GLP-1s. It competes with Found on the same weight-loss consumer target through an app-based coaching-first approach.
- LifeMD: LifeMD is a telehealth platform offering weight management programs including GLP-1 medications through its direct-to-consumer brands. It is a comparable smaller-scale direct competitor.
Broad incumbents
- WeightWatchers (WW): WW expanded into telehealth weight management via its acquisition of Sequence and now offers GLP-1 prescribing alongside its established points-based program. WW is a broad incumbent with overlapping but differentiated offerings.
- Teladoc Health: Teladoc is a broad telehealth incumbent with chronic condition management offerings that increasingly overlap with obesity care. Comparable as a telehealth infrastructure and chronic care competitor, though not weight-loss specialized.
- Amwell: Amwell provides enterprise telehealth infrastructure and chronic care programs used by payers and providers. It overlaps with Found indirectly through payer-partnered virtual care delivery rather than direct-to-consumer weight loss.
Emerging players
- Eli Lilly (LillyDirect): LillyDirect is Eli Lilly's direct-to-patient platform for dispensing Zepbound and other GLP-1s. It is both a partner and emerging competitive threat as it potentially disintermediates telehealth platforms on branded medication fulfillment.
- Mochi Health: Mochi Health is an emerging obesity-medicine telehealth platform offering GLP-1 prescribing and care coordination. It targets the same patient segment as Found with a comparable weight-care-focused model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Found social profiles
Digital presenceFound compliance and trust
Trust signalCompliance1 record
Found financial estimates
Financial estimateRevenue estimate
Valuation estimate
Found leadership team
Management profileNumber of profiles
Profiles4 records
Found funding detail
Funding detailFunding overview
Funding rounds3 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Found M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Found
What does Found do?
Found operates a direct-to-consumer telehealth weight care platform delivering personalized obesity treatment through board-certified clinicians, prescription medications (compounded GLP-1s, branded GLP-1s including Wegovy and Zepbound, the oral GLP-1 Foundayo/orforglipron, and non-GLP-1 options), a GLP-1 microdosing program, 1:1 health coaching, and an in-app community with behavior change support. Members access care through a web portal and mobile app, receive medications via partner pharmacies, and may use insurance coverage for clinical visits with most paying under $30 per visit.
Is Found a public or private company?
Found is a private company. It is classified as venture growth investor backed and is currently operating.
When was Found founded?
Found was founded in 2019. It employs 101 to 250 people.
Where is Found based?
Found is headquartered in San Francisco, United States, in the North America region.
How does Found make money?
Four revenue lines are on record. Subscription Fees (Membership) is the primary driver. The others are medication Sales, clinical Visit Fees (Insurance Billable) and laboratory Services.
Who are Found's main competitors?
Direct peers on record are Ro, Hims & Hers Health, Calibrate, Noom and LifeMD. Broad incumbents are WeightWatchers (WW), Teladoc Health and Amwell. Emerging players are Eli Lilly (LillyDirect) and Mochi Health.
Does Found have an API?
No public API is recorded for Found.
What industry is Found in?
Found's product category is Telehealth Weight Management. Its primary akta.pro industry code is HLAKADAL, Obesity Medicine & Weight Management, with a secondary code of HLALAGAD, Endocrinology & Diabetes Telemedicine Platforms. Its NAICS code is 812191 and its SIC code is 8011.